The inter-study reproducibility of instantaneous wave-free ratio and angiography coregistration.


Journal

Journal of cardiology
ISSN: 1876-4738
Titre abrégé: J Cardiol
Pays: Netherlands
ID NLM: 8804703

Informations de publication

Date de publication:
05 2020
Historique:
received: 01 08 2019
revised: 10 09 2019
accepted: 20 09 2019
pubmed: 2 11 2019
medline: 20 4 2021
entrez: 1 11 2019
Statut: ppublish

Résumé

Coregistration system of instantaneous wave-free ratio (iFR) pullback and angiography has been developed to enhance benefits of physiology oriented percutaneous coronary intervention (PCI), but its reproducibility has not yet been fully assessed. In 51 coronary arteries from 39 patients with stable coronary artery disease, iFR angio-coregistrations were repeated twice. The mean iFR values were comparable between the first and second studies (0.85 ± 0.12 vs. 0.84 ± 0.13, p = 0.97). In terms of a coronary segment with predominant iFR gradients defined by the largest segmental iFR gradients, the repeated iFR angio-coregistrations matched in 47 of 51 (92%) studies and showed good agreement (κ = 0.75) in overall vessels. When assessed only in vessels with positive iFR (≤0.89), iFR angio-coregistrations matched in 31 of 32 (97%) studies and showed an excellent agreement (κ = 0.91). The predominant iFR gradients in the repeated iFR angio-coregistrations demonstrated strong correlation (r = 0.96, p < 0.0001) and an excellent agreement: mean difference was 0.0006, and the lower and upper limits (mean difference ± 1.96 standard deviation) of agreement were -0.0312 and 0.0324. iFR angio-coregistration is highly reproducible and can precisely identify a suitable target for PCI.

Sections du résumé

BACKGROUND
Coregistration system of instantaneous wave-free ratio (iFR) pullback and angiography has been developed to enhance benefits of physiology oriented percutaneous coronary intervention (PCI), but its reproducibility has not yet been fully assessed.
METHODS AND RESULTS
In 51 coronary arteries from 39 patients with stable coronary artery disease, iFR angio-coregistrations were repeated twice. The mean iFR values were comparable between the first and second studies (0.85 ± 0.12 vs. 0.84 ± 0.13, p = 0.97). In terms of a coronary segment with predominant iFR gradients defined by the largest segmental iFR gradients, the repeated iFR angio-coregistrations matched in 47 of 51 (92%) studies and showed good agreement (κ = 0.75) in overall vessels. When assessed only in vessels with positive iFR (≤0.89), iFR angio-coregistrations matched in 31 of 32 (97%) studies and showed an excellent agreement (κ = 0.91). The predominant iFR gradients in the repeated iFR angio-coregistrations demonstrated strong correlation (r = 0.96, p < 0.0001) and an excellent agreement: mean difference was 0.0006, and the lower and upper limits (mean difference ± 1.96 standard deviation) of agreement were -0.0312 and 0.0324.
CONCLUSIONS
iFR angio-coregistration is highly reproducible and can precisely identify a suitable target for PCI.

Identifiants

pubmed: 31668520
pii: S0914-5087(19)30315-6
doi: 10.1016/j.jjcc.2019.09.016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

507-512

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Auteurs

Daisuke Higashioka (D)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Yasutsugu Shiono (Y)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Takashi Kubo (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan. Electronic address: takakubo@wakayama-med.ac.jp.

Hironori Kitabata (H)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Takahiro Nishi (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Kosei Terada (K)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Hiroki Emori (H)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Masahiro Takahata (M)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Teruaki Wada (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Kunihiro Shimamura (K)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Yoshiki Matsuo (Y)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Yasushi Ino (Y)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Atsushi Tanaka (A)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Takeshi Hozumi (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Takashi Akasaka (T)

Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH